Development and pilot phase of a European MS register

The MS-ID (Multiple Sclerosis Information Dividend) project was initiated by the European Multiple Sclerosis Platform (EMSP) in 2007 in order to identify and address major inequalities of MS treatment and care and thus eliminate disparities across the EU. One major approach to reach these goals in t...

Full description

Bibliographic Details
Main Authors: Flachenecker, P, Khil, L, Bergmann, S, Kowalewski, M, Pascu, I, Perez-Miralles, F, Sastre-Garriga, J, Zwingers, T
Format: Article in Journal/Newspaper
Language:unknown
Published: SPRINGER HEIDELBERG 2010
Subjects:
Online Access:http://discovery.ucl.ac.uk/1030550/
id ftucl:oai:eprints.ucl.ac.uk.OAI2:1030550
record_format openpolar
spelling ftucl:oai:eprints.ucl.ac.uk.OAI2:1030550 2023-05-15T16:51:15+02:00 Development and pilot phase of a European MS register Flachenecker, P Khil, L Bergmann, S Kowalewski, M Pascu, I Perez-Miralles, F Sastre-Garriga, J Zwingers, T 2010-10 http://discovery.ucl.ac.uk/1030550/ unknown SPRINGER HEIDELBERG J NEUROL , 257 (10) 1620 - 1627. (2010) Multiple sclerosis Databases Registries Epidemiology MULTIPLE-SCLEROSIS DISABILITY Article 2010 ftucl 2013-11-10T03:54:07Z The MS-ID (Multiple Sclerosis Information Dividend) project was initiated by the European Multiple Sclerosis Platform (EMSP) in 2007 in order to identify and address major inequalities of MS treatment and care and thus eliminate disparities across the EU. One major approach to reach these goals in the longer term is the implementation of a European MS register for MS. The feasibility of an EU MS register was piloted among five countries (Germany, Iceland, Poland, Romania and Spain). Each country liaised with one documentation centre. Countries and test centres were both chosen in a way that a heterogeneous health care structure was provided. After reaching consensus about the data set, comprehension and acceptability of the two questionnaires-representing both the physician's and the patient's perspective-were tested with 20 MS patients in each country. In a 6-month data collection period, data from 547 patients were recorded. Most sections of the questionnaires were available for more than 90% of patients. The results obtained from the pilot phase of the European MS register indicate that it is feasible to collect standardized data across Europe. Thus, the European MS register may be a valuable instrument to compare treatment and care of MS across countries, estimate the cost of MS in Europe and monitor the implementation of and adherence to guidelines. It may help to reduce the disparities in MS care and treatment throughout Europe and eventually improve the quality of life of people with MS. Article in Journal/Newspaper Iceland University College London: UCL Discovery
institution Open Polar
collection University College London: UCL Discovery
op_collection_id ftucl
language unknown
topic Multiple sclerosis
Databases
Registries
Epidemiology
MULTIPLE-SCLEROSIS
DISABILITY
spellingShingle Multiple sclerosis
Databases
Registries
Epidemiology
MULTIPLE-SCLEROSIS
DISABILITY
Flachenecker, P
Khil, L
Bergmann, S
Kowalewski, M
Pascu, I
Perez-Miralles, F
Sastre-Garriga, J
Zwingers, T
Development and pilot phase of a European MS register
topic_facet Multiple sclerosis
Databases
Registries
Epidemiology
MULTIPLE-SCLEROSIS
DISABILITY
description The MS-ID (Multiple Sclerosis Information Dividend) project was initiated by the European Multiple Sclerosis Platform (EMSP) in 2007 in order to identify and address major inequalities of MS treatment and care and thus eliminate disparities across the EU. One major approach to reach these goals in the longer term is the implementation of a European MS register for MS. The feasibility of an EU MS register was piloted among five countries (Germany, Iceland, Poland, Romania and Spain). Each country liaised with one documentation centre. Countries and test centres were both chosen in a way that a heterogeneous health care structure was provided. After reaching consensus about the data set, comprehension and acceptability of the two questionnaires-representing both the physician's and the patient's perspective-were tested with 20 MS patients in each country. In a 6-month data collection period, data from 547 patients were recorded. Most sections of the questionnaires were available for more than 90% of patients. The results obtained from the pilot phase of the European MS register indicate that it is feasible to collect standardized data across Europe. Thus, the European MS register may be a valuable instrument to compare treatment and care of MS across countries, estimate the cost of MS in Europe and monitor the implementation of and adherence to guidelines. It may help to reduce the disparities in MS care and treatment throughout Europe and eventually improve the quality of life of people with MS.
format Article in Journal/Newspaper
author Flachenecker, P
Khil, L
Bergmann, S
Kowalewski, M
Pascu, I
Perez-Miralles, F
Sastre-Garriga, J
Zwingers, T
author_facet Flachenecker, P
Khil, L
Bergmann, S
Kowalewski, M
Pascu, I
Perez-Miralles, F
Sastre-Garriga, J
Zwingers, T
author_sort Flachenecker, P
title Development and pilot phase of a European MS register
title_short Development and pilot phase of a European MS register
title_full Development and pilot phase of a European MS register
title_fullStr Development and pilot phase of a European MS register
title_full_unstemmed Development and pilot phase of a European MS register
title_sort development and pilot phase of a european ms register
publisher SPRINGER HEIDELBERG
publishDate 2010
url http://discovery.ucl.ac.uk/1030550/
genre Iceland
genre_facet Iceland
op_source J NEUROL , 257 (10) 1620 - 1627. (2010)
_version_ 1766041364057817088